Search

Displaying results 6571 - 6580 of 8974 in total
  1. Drug

    BMS-777607

    go.drugbank.com/drugs/DB12064
    Investigational

    BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.

  2. Drug

    Tipelukast

    go.drugbank.com/drugs/DB12435
    Investigational

    Tipelukast is under investigation for the treatment of IPF and Idiopathic pulmonary fibrosis.

  3. Drug

    Pf-04531083

    go.drugbank.com/drugs/DB12468
    Investigational

    Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.

  4. Drug

    Metiamide

    go.drugbank.com/drugs/DB08805
    Experimental

    It was an intermediate product on the path to developing cimetidine.

  5. Drug

    SOT-107

    go.drugbank.com/drugs/DB05337
    Investigational

    This drug treat for a type of brain cancer called a high grade glioma brain tumour. About half of all brain tumours are gliomas.

  6. Drug

    Dimethyl sulfone

    go.drugbank.com/drugs/DB14090
    Investigational

    Mixtures: Conart-MSM Sachet for Oral Solution, Condrosa-MSM Sachet for Oral Solution
  7. Drug

    2,5-Dimethoxy-4-ethylthioamphetamine

    go.drugbank.com/drugs/DB13940
    Experimental

    2,5-Dimethoxy-4-ethylthioamphetamine (ALEPH-2) is a phenylisopropylamine derivative with alleged anxiolytic and hallucinogenic properties.

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  8. Drug

    Insulin beef

    go.drugbank.com/drugs/DB09456
    Approved

    Insulin beef has been discontinued in the US and Canada since 2017.

    Categories: Insulins and Analogues for Injection, Fast-Acting
  9. Drug

    Elocalcitol

    go.drugbank.com/drugs/DB06194
    Experimental

    Elocalcitol is a calcitriol analog for inhibition of prostate cell growth; in phase II clinical trial in patients with benign prostate hyperplasia (4/2004).

  10. Drug

    Fosravuconazole

    go.drugbank.com/drugs/DB15204
    Investigational

    Fosravuconazole is under investigation in clinical trial NCT03378661 (BENDITA BEnznidazole New Doses Improved Treatment and Associations).

    Categories: Antifungals for Systemic Use, Antifungals for Dermatological Use